Soligenix Announces Formation of Beh ƒ §et's Disease Medical Advisory Board
Stockwatch,
Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024 PRINCETON, N.J., Feb.
Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024 PRINCETON, N.J., Feb.
Phase 2a clinical study of SGX945 in Behçet’s Disease initiating in 2024 PRINCETON, N.J., Feb.
Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024 PRINCETON, N.J., Feb.
Soligenix Announces Formation of Behçet's Disease Medical Advisory Board PR Newswire PRINCETON, N.J., Feb.
Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024 PRINCETON, N.J., Feb.
Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024, /PRNewswire/ Soligenix, Inc.
Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024 PRINCETON, N.J.
Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024 PRINCETON, N.J., Feb.
Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024 PRINCETON, N.J., Feb.
Generic name: dusquetide Treatment for: Behcet's Disease PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc.
PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
News provided by Soligenix 08 Jan, 2024, 07:30 ET PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc.
, /PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
PRINCETON, N.J. Fast track is a designation that the FDA reserves for a drug intended to treat a serious or life-threatening…
FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease PR Newswire…
[08-January-2024] PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Loading...Loading...Loading... Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
KGET 17 Please enter a search term. Please enter a search term. News provided by Nov 30, 2023, 7:30 AM ET Pipeline Expansion of…
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Please enter a search term. Please enter a search term. News provided by Nov 30, 2023, 7:30 AM ET Pipeline Expansion of Novel…
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology, - Soligenix, Inc.
Pipeline Expansion of Novel Innate Defense Regulator Technology About Dusquetide Dusquetide has demonstrated safety and…
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
PRINCETON, N.J., Nov. 30, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J.
PRINCETON, N.J., Nov. 30, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J., Nov.
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…